1.NEU trading stats for the past 4 day week include:
*1767K shares traded via 12508 trades
*Average trade was 141 shares or approximately $1833 in value.
* The NEU share price retreated by 3c per share after all of the above activity over the past week.
2.Under the heading of Risk Assessment Neuren has an interesting financial statistical number [the Quick Ratio] of 25.77 which is high and would be rare for any company in any stock market.This ratio is often used by investors/analysts to determine a companys ability cover short term cash needs Any number above 1 is considered to be satisfactory By comparison the ASX average quick ratio number is 2.81 and the Neuren sector average is 4.55
[ The Quick Ratio [ also known as the "acid test"] is similar to the current ratio but excludes the value of inventory or stocks in the current asset calculation. The reasoning for this is that inventories are not always immediately realisable as a source of cash. Inventory can also be subject to valuation problems. The formula is current assets less inventory divided by current liabilities]..
Kens
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-4568
-
- There are more pages in this discussion • 6,299 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.43 |
Change
-0.095(0.46%) |
Mkt cap ! $2.606B |
Open | High | Low | Value | Volume |
$20.60 | $20.77 | $20.37 | $2.176M | 105.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 47 | $20.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.43 | 196 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 25 | 20.390 |
4 | 55 | 20.380 |
4 | 208 | 20.370 |
5 | 226 | 20.360 |
5 | 525 | 20.350 |
Price($) | Vol. | No. |
---|---|---|
20.400 | 1814 | 11 |
20.410 | 224 | 7 |
20.420 | 337 | 5 |
20.430 | 349 | 5 |
20.440 | 308 | 6 |
Last trade - 13.56pm 15/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online